Cover Image
市場調查報告書

迅速診斷的全球市場 (2016∼2020年)

Global Rapid Diagnostics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 357370
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
迅速診斷的全球市場 (2016∼2020年) Global Rapid Diagnostics Market 2016-2020
出版日期: 2016年04月28日 內容資訊: 英文 71 Pages
簡介

所謂迅速診斷檢驗,是為了在沒有設備、產品的狀態設計成迅速得到結果的診斷藥、設備。不但能攜帶到患者的病床和臨床現場等,可簡單操作、解讀,費用也便宜,而且也能在特殊的環境和極度的高溫、低溫下使用。由於馬上有結果,在體外診斷 (IVD) 的領域需求擴大。主要的診斷項目,有血糖值和血液凝固層級、心臟生物標記、感染疾病、血紅素濃度、白血球百分率 (5等級)、妊娠狀態等。全球迅速診斷市場,預計2016∼2020年以7.27%的年複合成長率成長。

本報告提供全球迅速診斷用產品的市場相關分析,市場概要和結構,市場規模趨勢 (今後5年的預測值),各用途、各產品、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 各用途的市場區隔

  • 全球迅速診斷市場:各用途
  • 血糖檢驗市場
  • 心血管代謝檢驗市場
  • 傳染病檢查市場
  • 妊娠、妊娠檢驗市場
  • 毒物檢驗市場
  • 大便潛血試驗市場
  • 血液凝固檢查市場

第7章 各產品的市場區隔

  • OTC (一般藥) 形式迅速診斷市場
  • 專門用迅速診斷市場

第8章 地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲各國 (EMEA) 市場
  • 亞太地區市場

第9章 推動市場要素

  • 對迅速、正確的檢驗的需求增加
  • 創新的迅速診斷套件、設備的銷售
  • 良好的法規、醫療費償付政策
  • 慢性疾病、感染疾病的發病數量的增加

第10章 推動因素的影響力

第11章 市場課題

  • 價格壓力
  • 迅速診斷套件的可靠性、穩定性相關課題
  • 受訓練的專家不足

第12章 推動因素、課題的影響力

第13章 市場趨勢

  • 在迅速診斷領域的數位平台的利用
  • NPO、政府的提高認知度的措施
  • 在低所得、中所得國家引進迅速診斷套件

第14章 供應商環境

  • 競爭方案
  • 市場佔有率分析
  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare
  • 其他卓越供應商

第15章 附錄

  • 簡稱集

第16章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR8251

About Rapid Diagnostics

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can be used at patient's bedside, and in physician's clinics, ICUs, operating rooms, emergency rooms, and inpatient wards. The healthcare professional attending to the patient obtains the specimen, performs an analysis, and records the result.

Technavio's analysts forecast the global rapid diagnostics market to grow at a CAGR of 7.27% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global rapid diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of rapid diagnostics products, including over-the-counter (OTC) rapid diagnostics tests (self-testing kits, glucose meters, and strips) and professional rapid diagnostics tests (test kits, handheld devices, and small analyser) have been considered.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Rapid Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere Inc.
  • Beckman Coulter Inc.
  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthcare

Other Prominent Vendors

  • Abaxis
  • Accriva Diagnostics
  • ACON Laboratories
  • A. Menarini Diagnostics
  • Bayer HealthCare
  • BD
  • Bio-AMD
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • DiagCor Bioscience
  • Diasorin
  • Eiken Chemical
  • GlySens
  • Helena Laboratories
  • Hemosure
  • Hologic
  • Humor Diagnostica
  • LifeScan
  • Meridian Life Sciences
  • Nipro Diagnostics
  • Oasis Diagnostics
  • OPKO Health
  • OraSure Technologies
  • Quidel
  • Randox Laboratories
  • Sysmex
  • Trinity Biotech
  • Trivitron Healthcare
  • URIT

Market driver

  • Increase in incidence of chronic and infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • Pricing pressures
  • For a full, detailed list, view our report

Market trend

  • Use of digital platforms in rapid diagnostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Global rapid diagnostics market by application
  • Blood glucose rapid diagnostics
  • Cardiometabolic rapid diagnostics
  • Infectious disease rapid diagnostics
  • Pregnancy and fertility rapid diagnostics
  • Toxicology rapid diagnostics
  • Fecal occult blood rapid diagnostics
  • Coagulation rapid diagnostics

PART 07: Market segmentation by product

  • OTC rapid diagnostics test
  • Professional rapid diagnostics test

PART 08: Geographical segmentation

  • Rapid diagnostics market in Americas
  • Rapid diagnostics market in EMEA
  • Rapid diagnostics market in APAC

PART 09: Market drivers

  • Growing demand for rapid and accurate testing
  • Launch of innovative rapid diagnostic kits and devices
  • Favorable regulatory and reimbursement policies
  • Increase in incidence of chronic and infectious diseases

PART 10: Impact of drivers

PART 11: Market challenges

  • Pricing pressures
  • Issues with reliability and stability of rapid diagnostic kits
  • Lack of trained professionals

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Use of digital platforms in rapid diagnostics
  • Initiatives by non-profit entities and governments to increase awareness
  • Adoption of rapid diagnostic kits in middle- and low-income countries

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global rapid diagnostics market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global rapid diagnostics market by application
  • Exhibit 05: Global rapid diagnostics market by application 2015
  • Exhibit 06: Global rapid diagnostics market by application 2020
  • Exhibit 07: Global rapid diagnostics market by application 2015-2020
  • Exhibit 08: Global blood glucose rapid diagnostics market 2015-2020 ($ billions)
  • Exhibit 09: Global cardiometabolic rapid diagnostics market 2015-2020 ($ billions)
  • Exhibit 10: Segmentation of global cardiometabolic rapid diagnostics market by application
  • Exhibit 11: Segmentation of global cardiometabolic rapid diagnostics market by application 2015
  • Exhibit 12: Global blood gas rapid diagnostics market 2015-2020 ($ billions)
  • Exhibit 13: Global cardiac marker rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 14: Global HbA1c rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 15: Global lipids rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 16: Global infectious disease rapid diagnostics market 2015-2020 ($ billions)
  • Exhibit 17: Global infectious disease rapid diagnostics market by application
  • Exhibit 18: Segmentation of global infectious disease rapid diagnostics market by application 2015
  • Exhibit 19: Global infectious disease rapid diagnostics market by application 2014-2019
  • Exhibit 20: Global respiratory illnesses rapid diagnostic testing market 2015-2020 ($ millions)
  • Exhibit 21: Global hepatitis rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 22: Global HAI rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 23: Global tropical diseases rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 24: Global sexual health rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 25: Demographic statistics for HIV 2014
  • Exhibit 26: Global HIV rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 27: Global pregnancy and fertility rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 28: Global toxicology rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 29: Global fecal occult blood rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 30: Global coagulation rapid diagnostics market 2015-2020 ($ millions)
  • Exhibit 31: Segmentation of global rapid diagnostics market by product 2015
  • Exhibit 32: Segmentation of global rapid diagnostics market by geography 2015
  • Exhibit 33: Segmentation of global rapid diagnostics market by geography 2020
  • Exhibit 34: Segmentation of global rapid diagnostics market by geography 2015-2020
  • Exhibit 35: Rapid diagnostics market in Americas 2015-2020 ($ billions)
  • Exhibit 36: Rapid diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 37: Rapid diagnostics market in APAC 2015-2020 ($ billions)
  • Exhibit 38: Impact of drivers
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Ranking of key vendors 2015
  • Exhibit 41: Product portfolio of vendors by application
  • Exhibit 42: Abbott Diagnostics: Key takeaways
  • Exhibit 43: Alere: Key takeaways
  • Exhibit 44: Beckman Coulter: Key takeaways
  • Exhibit 45: Roche Diagnostics: Key takeaways
  • Exhibit 46: Siemens Healthcare: Key takeaways
Back to Top